Once again, immunotherapy is set to be a very hot topic at the American Society of Clinical Oncology annual meeting, held this year from May 30 to June 3 in Chicago.
ASCO Immunotherapy Alert: BioMedTracker’s Top Abstract Picks
With cancer checkpoint inhibitors extremely high on the radar at the upcoming American Society of Clinical Oncology annual meeting, BioMedTracker analysts identify the most compelling immunotherapy abstracts.
More from Clinical Trials
• By
Both the EU Clinical Trials Regulation and the European Health Data Space Regulation have the potential to improve harmonization and be highly valuable for industry – but the importance of protecting company data will be paramount, a life sciences consultant says.
• By
The policy expectation that the model clinical trial agreements are used without modification is in line requests from industry and the NHS/HSC.
• By
DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.
• By
Pharmaceutical companies need to “pressure test” their clinical development strategies early for health technology assessment purposes, particularly in light of the new EU HTA Regulation, a life sciences consultant says.